Study Notes on Psychiatric Disorders from Principles of Pharmacology for Athletic Trainers
Chapter 13: Psychiatric Disorders
Overview
Authors: Houglum J, Harrelson G.
Source: Principles of Pharmacology for Athletic Trainers, Second Edition. © 2011 SLACK Incorporated.
Major Neurotransmitters in the Brain
Neurotransmitters play essential roles in signaling, with key types including:
Serotonin (5-HT)
Norepinephrine (NE)
Dopamine (DA)
γ-Aminobutyric acid (GABA)
They are housed in vesicles, transported by transporters, and act on receptors on the cell surface.
Major Depression
Definition: A mood disorder characterized by persistent feelings of sadness and loss of interest.
Causes:
Not fully understood but involves decreased levels of serotonin and norepinephrine.
Can onset due to medications or medical conditions.
Affects women twice as frequently as men and is not dependent on age.
Symptoms of Major Depression
Important symptoms include:
Depressed mood
Loss of interest or pleasure in activities
Change in appetite or sleep patterns
Loss of energy
Feelings of worthlessness or guilt
Diminished ability to concentrate
Suicidal thoughts
Antidepressants
Categories include:
Tricyclic Antidepressants (TCAs)
Selective Serotonin Reuptake Inhibitors (SSRIs)
Monoamine Oxidase Inhibitors (MAOIs)
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
Selective Serotonin Reuptake Inhibitors (SSRIs)
Definition: These are currently the most commonly used antidepressants.
Mechanism of Action (MOA): They inhibit the reuptake of serotonin in presynaptic neurons, enhancing serotonin levels in the synaptic cleft.
Examples:
Fluoxetine (Prozac, Sarafem)
Sertraline (Zoloft)
Paroxetine (Paxil, Paxil CR)
Fluvoxamine (Luvox)
Citalopram (Celexa)
Escitalopram (Lexapro)
Adverse Effects of SSRIs
Common side effects include:
Sexual dysfunction
Nausea and vomiting
Headache
CNS stimulation
Potential “Serotonin Syndrome”
Therapy Considerations for SSRIs
Time of Day Taken: Administration in the morning is often preferred.
Onset of Effect: Slow effect with maximum response in 4 to 6 weeks.
Discontinuation: Must gradually decrease the dose when discontinuing the medication.
Serotonin/Norepinephrine Reuptake Inhibitors (SNRIs)
Influence on serotonin and norepinephrine levels, having a better side effect profile than TCAs.
Examples:
Venlafaxine (Effexor)
Duloxetine (Cymbalta)
Desvenlafaxine (Pristiq)
Tricyclic Antidepressants (TCAs)
Mechanism of Action: Block the reuptake of serotonin and norepinephrine and also block cholinergic receptors.
Examples:
Imipramine (Tofranil)
Amitriptyline (Elavil)
Nortriptyline (Pamelor)
Desipramine (Norpramin)
Clomipramine (Anafranil)
Doxepin (Sinequan)
Protriptyline (Vivactil)
Trimipramine (Surmontil)
Adverse Effects of TCAs
Notable side effects include:
Orthostatic hypotension
Anticholinergic effects
Sedation
Cardiac toxicity
Seizures
Weight gain
Sexual dysfunction
Increased sweating
TCA Therapy Considerations
Onset of Action: Slow, requires about 3 to 4 weeks.
Noncompliance Rate:High due to adverse effects.
Narrow Therapeutic Index: Abrupt discontinuation leads to withdrawal symptoms.
Monoamine Oxidase Inhibitors (MAOIs)
Rarely Used:
They inhibit monoamine oxidase, thus decreasing the breakdown of norepinephrine and serotonin.
Known for many drug and food interactions.
Examples: Nardil and Parnate.
Bupropion
Indicated for major depression and smoking cessation.
Mechanism: Mild norepinephrine/dopamine reuptake inhibitor.
Considerations: Well tolerated; can cause seizures at higher doses.
Tetracyclics
Affect multiple receptors and increase serotonin and norepinephrine.
Example: Mirtazapine.
Adverse Effects: Include somnolence, dizziness, weight gain, increased cholesterol, and mild anticholinergic effects.
Trazodone (Desyrel)
Less effective compared to other antidepressants.
Primarily causes significant sedation and is used for insomnia.
Other Adverse Effects: Dizziness and orthostatic hypotension.
Bipolar Disorder
Serious mental disorder characterized by mood swings ranging from manic episodes to depressive states.
Symptom Domains of Bipolar Disorder
Manic mood and behavior:
Euphoria
Grandiosity
Pressured speech
Impulsivity
Excessive libido
Dysphoric or Negative Mood:
Depression, anxiety, irritability, hostility, violence, recklessness, diminished need for sleep, social intrusiveness, and psychotic symptoms (delusions and hallucinations).
Cognitive Symptoms:
Racing thoughts, distractibility, disorganization, inattentiveness.
Treatment of Bipolar Disorder
Antidepressants: Used to treat acute depressive episodes but with lower doses and shorter durations than for major depression.
Lithium (Li+):
Uses: Treats acute manic episodes and prevents reoccurrence of mania and depression.
MOA: Unclear.
Adverse Effects: Nausea, diarrhea, confusion, muscle weakness, headache, polydipsia, polyuria, fine hand tremors. Long-term effects may include renal toxicity, goiter, and hypothyroidism.
Therapy Considerations: Requires multiple daily doses due to a low therapeutic index and toxicity risk. Advise patients to stay hydrated (2-3 liters of water daily).
Valproic Acid (VPA)
A mood stabilizer with an unknown mechanism, effective for acute manic episodes and maintenance therapy.
Adverse Effects: Might include nausea, diarrhea, sedation, weight gain, prolonged bleeding time, alopecia, hepatitis, thrombocytopenia.
Carbamazepine
Another mood stabilizer for acute mania and maintenance therapy, with an unclear mechanism.
Adverse Effects: Nausea, vomiting, diarrhea, drowsiness, confusion, headache, dizziness, vertigo, blurred vision.
Drug Interactions: Induces P450 enzymes, increasing metabolism of other drugs and its own metabolism, while inhibitors increase its concentration.
Antipsychotics in Bipolar Disorder
Used alone or with mood stabilizers for treating acute manic episodes and maintenance therapy.
Atypical Antipsychotics: Generally preferred.
Anxiety Disorders
Characterized by excessive fear or anxiety in a way that disrupts daily function.
Key neurotransmitters involved include norepinephrine, serotonin, dopamine, and GABA.
Generalized Anxiety Disorder (GAD)
Defined as excessive, uncontrollable worry lasting over six months, often co-existing with other psychiatric disorders.
Panic Disorder
Involves recurrent panic attacks coupled with persistent concerns and behavior changes regarding the attacks.
Social Anxiety Disorder (SAD)
The most common anxiety disorder characterized by intense fear of negative evaluation in social situations, leading to avoidance behavior.
Obsessive-Compulsive Disorder (OCD)
Characterized by obsessions (recurring intrusive thoughts) and compulsions (ritualistic behavior).
Post-Traumatic Stress Disorder (PTSD)
Develops following a traumatic event, involving symptoms such as flashbacks and recurring thoughts of the event.
Drug Therapy for Anxiety Disorders
SSRIs and SNRIs are the preferred treatments, alongside benzodiazepines and buspirone (BuSpar), especially for generalized anxiety disorders.
Benzodiazepines:
MOA: Potentiate GABA effects, causing CNS depression. They have potential for abuse and withdrawal symptoms.
Examples: Alprazolam, Lorazepam, Diazepam, Clonazepam.
Buspirone
Duration: Takes 4 to 6 weeks for maximum effect with no abuse potential.
Considerations: Good long-term therapy option for anxiety without sedation.
Treatment Strategies
Performance Anxiety: β-blockers are commonly used to alleviate autonomic symptoms. Administered prior to events for management of stage fright.
Obsessive-Compulsive Disorder Treatment
SSRIs are the primary treatment, with the average dose higher than that used for other anxiety disorders.
Schizophrenia
A chronic mental disorder with a complex etiology likely involving a genetic component and neurotransmitter disturbances, primarily dopamine and serotonin.
Symptoms of Schizophrenia
Divided into positive, negative, and cognitive symptoms:
Positive Symptoms: Hallucinations, delusions, paranoia.
Negative Symptoms: Diminished motivation, emotional expression, and social withdrawal.
Cognitive Symptoms: Disordered thoughts, attention deficits, and memory difficulties.
Antipsychotic Treatments
Typical Antipsychotics: Such as Haloperidol and Chlorpromazine, with notable side effects like extrapyramidal symptoms.
Atypical Antipsychotics: Considered the drugs of choice due to a lower risk of extrapyramidal side effects and broader efficacy.
Examples: Clozapine, Olanzapine, Risperidone, Quetiapine, Ziprasidone, Paliperidone, Aripiprazole.
Clozapine: Noted for its effectiveness but has a risk of agranulocytosis requiring regular blood monitoring.
Treatment Goals for Schizophrenia
Address acute episodes, prevent recurrences, optimize functioning, minimize side effects, and improve adherence. Atypical agents are first-line except for Clozapine.
Attention Deficit/Hyperactivity Disorder (ADHD)
Characterized by inattention, hyperactivity, and impulsivity, with genetic links suggested.
Treatment Goals
Aim to improve focus, reduce impulsivity, and minimize adverse effects of therapy.
Drug Therapy for ADHD
Central Nervous System (CNS) stimulants are frequently used:
Examples:
Methylphenidate (Ritalin)
Dexmethylphenidate (Focalin)
Amphetamines (Adderall, Vyvanse).
Adverse Effects of CNS Stimulants: Decreased appetite, insomnia, anxiety, irritability, and rapid speech.
Non-Stimulant Treatment Options
Atomoxetine (Strattera): Selective norepinephrine reuptake inhibitor, with considerations around increased suicide risk.
Sleep Disorders
Disorders characterized by disrupted sleep patterns.
Types of Sleep Disorders
Insomnia: Difficulty falling or staying asleep.
Narcolepsy: Excessive daytime sleepiness treated with CNS stimulants such as Modafinil.
Sleep Apnea: Treated with devices like CPAP.
Drug Therapy for Sleep Disorders
Benzodiazepines and Benzodiazepine-like Drugs: Common options for insomnia, with drug therapy recommendations aimed at employing the lowest effective doses for the shortest time.
Antidepressants: Certain antidepressants used off-label for sleep issues, such as amitriptyline and trazodone.
OTC Sleep Aids
Common options include first-generation antihistamines like diphenhydramine, melatonin supplements, and valerian root, each considered for their effects on promoting sleep onset.
Eating Disorders
Major types include:
Anorexia Nervosa: Characterized by self-imposed starvation and excessive thinness.
Bulimia Nervosa: Characterized by binge eating followed by purging.
Treatment Approaches
Primarily involve psychotherapy and nutritional counseling.
Anorexia nervosa currently lacks FDA-approved medications, while bulimia nervosa sees use of SSRIs, particularly Fluoxetine which is FDA approved.